Approvals/TGA/ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution

Approved

STANDARD

ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution

Approval Id: cbe50040324ff8ad
Product Name: ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution
Artg Id: 53362
Artg Name: ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution
Sponsor: Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path: /organization/sanofi-aventis-healthcare-pty-ltd
Artg Date: 1995-08-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/fb37d2a90b5d905d014f0f75d24a77eb.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 31, 2025

Approval ID

cbe50040324ff8ad

Type

Standard